---
figid: PMC8047470__fonc-11-627549-g007
figtitle: Effects of hypoxic or oxygenated TME on the fate, functionality, and antitumor
  activity of T cell or CAR T cells
organisms:
- Homo sapiens
- Mus musculus
- Escherichia coli
- Canis lupus familiaris
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8047470
filename: fonc-11-627549-g007.jpg
figlink: pmc/articles/PMC8047470/figure/f7/
number: F7
caption: The effects of hypoxic or oxygenated TME on the fate, functionality, and
  antitumor activity of T cell or CAR T cells. The upper panel shows the hypoxic TME.
  In this condition, the low level of O2 leads to the stabilization of HIF-1α which
  elevates the expression level of CD39 and CD73 leading to the excessive production
  of adenosine. Adenosine binds to A2AR causing an elevation in the level of cAMP,
  and cAMP activates PKA. Further on, PKA inhibits TCR and CAR signaling and upregulates
  the expression of immunosuppresion contributors via CRE. Moreover, HIF-1α elevates
  the expression level of immunosuppressive genes through HRE. The activated CRE and
  HRE signaling cascades together reduce the level of INF-γ, IL-12, and IL-2 expression
  and upregulate TGF-β, IL-10, PD-1, CTLA-4, COX-2, and Treg expression. In the lower
  panel, supplemental oxygenation or using oxygenation agents elevates the level of
  O2, therefore, the downstream signaling pathway cannot proceed as it would in the
  case of a hypoxic microenvironment. TME, tumor microenvironment; HIF-1α, Hypoxia-inducible
  factor-1α; A2AR, A2A adenosine receptor; PKA, protein kinase A; CRE, cAMP Response
  Element; CREB, cAMP Response Element-Binding Protein; HRE, Hypoxia Response Element;
  TCR, T cell receptor; CAR, chimeric antigen receptor.
papertitle: Strategies for Dodging the Obstacles in CAR T Cell Therapy.
reftext: Pooria Safarzadeh Kozani, et al. Front Oncol. 2021;11:627549.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9542247
figid_alias: PMC8047470__F7
figtype: Figure
redirect_from: /figures/PMC8047470__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8047470__fonc-11-627549-g007.html
  '@type': Dataset
  description: The effects of hypoxic or oxygenated TME on the fate, functionality,
    and antitumor activity of T cell or CAR T cells. The upper panel shows the hypoxic
    TME. In this condition, the low level of O2 leads to the stabilization of HIF-1α
    which elevates the expression level of CD39 and CD73 leading to the excessive
    production of adenosine. Adenosine binds to A2AR causing an elevation in the level
    of cAMP, and cAMP activates PKA. Further on, PKA inhibits TCR and CAR signaling
    and upregulates the expression of immunosuppresion contributors via CRE. Moreover,
    HIF-1α elevates the expression level of immunosuppressive genes through HRE. The
    activated CRE and HRE signaling cascades together reduce the level of INF-γ, IL-12,
    and IL-2 expression and upregulate TGF-β, IL-10, PD-1, CTLA-4, COX-2, and Treg
    expression. In the lower panel, supplemental oxygenation or using oxygenation
    agents elevates the level of O2, therefore, the downstream signaling pathway cannot
    proceed as it would in the case of a hypoxic microenvironment. TME, tumor microenvironment;
    HIF-1α, Hypoxia-inducible factor-1α; A2AR, A2A adenosine receptor; PKA, protein
    kinase A; CRE, cAMP Response Element; CREB, cAMP Response Element-Binding Protein;
    HRE, Hypoxia Response Element; TCR, T cell receptor; CAR, chimeric antigen receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Entpd1
  - Hif1a
  - Adora2a
  - .na.character
  - Wdtc1
  - Mdga2
  - Trav6-3
  - Nr1i3
  - Casr
  - Cxadr
  - Rcvrn
  - Trim13
  - Arr3
  - Creb1
  - Cartpt
  - Slc22a18
  - tm
  - Tme
  - ENTPD1
  - ATP8A2
  - HIF1A
  - ADORA2A
  - APRT
  - MFAP1
  - WDTC1
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CASR
  - CXADR
  - SPG7
  - NR1I3
  - TRIM13
  - CXADRP1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - CARTPT
  - SLC22A18
  - ATPsynbeta
  - Atpalpha
  - sima
  - Amph
  - Low
  - adp
  - Tcr
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - car
  - CrebB
  - CrebA
  - mirr
  - CarT
  - ATP
  - AMP
  - Jadenosine
  - ADP
  - CAMP
  - TCR
  - adenosine
  - CAR-T
---
